DK0882725T3 - Quinoloncarboxylsyrederivater eller deres salte - Google Patents

Quinoloncarboxylsyrederivater eller deres salte

Info

Publication number
DK0882725T3
DK0882725T3 DK97902618T DK97902618T DK0882725T3 DK 0882725 T3 DK0882725 T3 DK 0882725T3 DK 97902618 T DK97902618 T DK 97902618T DK 97902618 T DK97902618 T DK 97902618T DK 0882725 T3 DK0882725 T3 DK 0882725T3
Authority
DK
Denmark
Prior art keywords
salts
acid derivatives
optionally substituted
carboxylic acid
halogeno
Prior art date
Application number
DK97902618T
Other languages
English (en)
Inventor
Yozo Todo
Kazuya Hayashi
Masahiro Takahata
Yasuo Watanabe
Hirokazu Narita
Original Assignee
Toyama Chemical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Toyama Chemical Co Ltd filed Critical Toyama Chemical Co Ltd
Application granted granted Critical
Publication of DK0882725T3 publication Critical patent/DK0882725T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/475Quinolines; Isoquinolines having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00Compounds containing elements of Groups 3 or 13 of the Periodic Table
    • C07F5/02Boron compounds
    • C07F5/025Boronic and borinic acid compounds

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Indole Compounds (AREA)
DK97902618T 1996-02-09 1997-02-07 Quinoloncarboxylsyrederivater eller deres salte DK0882725T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP4793696 1996-02-09
PCT/JP1997/000317 WO1997029102A1 (en) 1996-02-09 1997-02-07 Quinolonecarboxylic acid derivatives or salts thereof

Publications (1)

Publication Number Publication Date
DK0882725T3 true DK0882725T3 (da) 2003-01-13

Family

ID=12789268

Family Applications (1)

Application Number Title Priority Date Filing Date
DK97902618T DK0882725T3 (da) 1996-02-09 1997-02-07 Quinoloncarboxylsyrederivater eller deres salte

Country Status (18)

Country Link
US (1) US6025370A (da)
EP (1) EP0882725B1 (da)
KR (1) KR100276477B1 (da)
CN (2) CN100395244C (da)
AT (1) ATE229950T1 (da)
AU (1) AU711914B2 (da)
CA (1) CA2242242C (da)
DE (1) DE69717970T2 (da)
DK (1) DK0882725T3 (da)
ES (1) ES2188890T3 (da)
HK (1) HK1039118B (da)
HU (1) HU228567B1 (da)
IL (1) IL124944A (da)
NO (1) NO316666B1 (da)
NZ (1) NZ330775A (da)
PT (1) PT882725E (da)
WO (1) WO1997029102A1 (da)
ZA (1) ZA971023B (da)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2321042T3 (es) 1997-09-15 2009-06-01 THE PROCTER & GAMBLE COMPANY Quinolonas antimicrobianas, composiciones y usos de las mismas.
US6387928B1 (en) 1997-09-15 2002-05-14 The Procter & Gamble Co. Antimicrobial quinolones, their compositions and uses
NZ504084A (en) * 1997-10-27 2003-02-28 Toyama Chemical Co Ltd Processes for producing 7-isoindolinequinolonecarboxylic derivatives and its intermediates, as well as salts of 7-isoindolinequinolonecarboxylic acid derivatives, its hydrates and composition comprising the same as active ingredient
JP3281872B2 (ja) 1998-03-20 2002-05-13 富山化学工業株式会社 7−イソインドリン−3−キノリンカルボン酸の塩、その水和物およびそれらを活性成分とする組成物
BRPI9909456B8 (pt) * 1998-04-06 2021-07-06 Toyama Chemical Co Ltd Ácido quinolonecarboxílico ou sais dos mesmos
JP4499846B2 (ja) * 1998-05-07 2010-07-07 富山化学工業株式会社 7−イソインドリン−キノロンカルボン酸誘導体の製造法並びにイソインドリン−5−ボロン酸誘導体の製造法
JP4549461B2 (ja) * 1998-08-31 2010-09-22 富山化学工業株式会社 7−ブロモ−キノロンカルボン酸誘導体の製造法
JP2000229946A (ja) * 1998-12-10 2000-08-22 Toyama Chem Co Ltd キノロンカルボン酸の製造法およびその中間体
CA2367373C (en) 1999-03-17 2011-09-20 Daiichi Pharmaceutical Co., Ltd. Medicinal compositions
WO2003077842A2 (en) * 2002-03-12 2003-09-25 Bristol-Myers Squibb Company Palatable oral suspension and method
WO2004113321A1 (ja) * 2003-06-19 2004-12-29 Daiichi Pharmaceutical Co., Ltd. 選択的なアミノ置換基導入法
DE10337191A1 (de) * 2003-08-13 2005-03-17 Bayer Healthcare Ag Neue Verwendung von Chinolon-Antibiotika
KR100981351B1 (ko) * 2003-10-29 2010-09-10 주식회사 엘지생명과학 7-클로로-1-사이클로프로필-6-플루오로-4-옥소-1,4-디하이드로-1,8-나프티리딘-3-카복실산의 제조방법
US20090156577A1 (en) * 2004-09-09 2009-06-18 Benjamin Davis 7-amino alkylidenyl-heterocyclic quinolones and naphthyridones
KR101408393B1 (ko) * 2005-03-03 2014-06-17 제이엔씨 주식회사 클로로플루오로벤젠 액정 화합물, 액정 조성물, 및 액정표시 소자
EP1999106B1 (en) 2006-03-28 2012-06-27 TaiGen Biotechnology Co., Ltd. A hydride reduction process for preparing quinolone intermediates
WO2007110835A2 (en) 2006-03-28 2007-10-04 The Procter & Gamble Company A coupling process for preparing quinolone intermediates
US7902227B2 (en) * 2007-07-27 2011-03-08 Janssen Pharmaceutica Nv. C-7 isoxazolinyl quinolone / naphthyridine derivatives useful as antibacterial agents
CN101298418B (zh) * 2008-06-13 2010-12-15 江苏康鹏农化有限公司 3-氧代-3-(2,4-二卤代-3-二氟甲氧基苯基)丙酸乙酯的制备方法
CN102212056A (zh) * 2010-04-09 2011-10-12 山东轩竹医药科技有限公司 新的双环喹诺酮类化合物
WO2013121439A2 (en) * 2012-02-15 2013-08-22 Glenmark Generics Limited Process for garenoxacin mesylate
CA2904387C (en) 2013-03-15 2021-12-07 Melinta Therapeutics, Inc. Methods of treating infections in overweight and obese patients using antibiotics
GB201516614D0 (en) * 2015-09-18 2015-11-04 Redx Pharma Plc Antibacterial compounds
CN105837555B (zh) * 2016-03-31 2019-01-25 南京华威医药科技集团有限公司 加雷沙星及其中间体制备方法
CN111620901B (zh) * 2020-06-08 2023-03-21 蚌埠医学院第二附属医院 一种含硅氧烷基的氟喹诺酮化合物、其制备方法及用途

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6199835A (ja) * 1984-10-22 1986-05-17 Shimadzu Corp 振動試験機の波形補正装置
MY105136A (en) * 1988-04-27 1994-08-30 Daiichi Seiyaku Co Optically active pyridonecarboxylic acid derivatives.
RU2049777C1 (ru) * 1989-08-16 1995-12-10 Пфайзер Инк. Азабицикло-хинолон-карбоновые кислоты или их фармацевтически приемлемые кислотно-аддитивные соли и промежуточные продукты для их получения
EG20543A (en) * 1992-10-30 1999-07-31 Procter & Gamble Process for preparing of novel antimicrobial -5- (n-heterosubstituted amino) quinolones
JPH07300472A (ja) * 1992-12-28 1995-11-14 Korea Res Inst Chem Technol 新規キノロンカルボン酸誘導体およびその製造方法
JPH06199835A (ja) * 1993-01-08 1994-07-19 Hokuriku Seiyaku Co Ltd 8−ジフルオロメトキシキノリン−3−カルボン酸誘導体
DE4301246A1 (de) * 1993-01-19 1994-07-21 Bayer Ag Chinolon- und Naphthyridoncarbonsäurederivate
JPH0848629A (ja) * 1994-08-08 1996-02-20 Dainippon Pharmaceut Co Ltd ピリドンカルボン酸誘導体およびそれを有効成分とする抗ピロリ菌剤
ATE245638T1 (de) * 1994-08-12 2003-08-15 Toyama Chemical Co Ltd Neue chinolon- oder naphthyridoncarbonsäurederivate oder deren salze

Also Published As

Publication number Publication date
HK1039118B (zh) 2009-01-30
AU1670197A (en) 1997-08-28
DE69717970T2 (de) 2003-04-30
EP0882725A4 (en) 1999-05-06
US6025370A (en) 2000-02-15
CA2242242C (en) 2001-08-07
DE69717970D1 (de) 2003-01-30
EP0882725A1 (en) 1998-12-09
KR19990082406A (ko) 1999-11-25
ATE229950T1 (de) 2003-01-15
AU711914B2 (en) 1999-10-21
NZ330775A (en) 1999-08-30
ZA971023B (en) 1997-09-25
KR100276477B1 (ko) 2000-12-15
NO983625D0 (no) 1998-08-07
PT882725E (pt) 2003-04-30
CA2242242A1 (en) 1997-08-14
IL124944A (en) 2003-06-24
CN1210533A (zh) 1999-03-10
ES2188890T3 (es) 2003-07-01
IL124944A0 (en) 1999-01-26
HUP9901966A2 (hu) 1999-09-28
HU228567B1 (en) 2013-04-29
NO983625L (no) 1998-08-07
EP0882725B1 (en) 2002-12-18
WO1997029102A1 (en) 1997-08-14
HK1039118A1 (zh) 2002-04-12
HUP9901966A3 (en) 2002-01-28
CN1100053C (zh) 2003-01-29
NO316666B1 (no) 2004-03-29
CN100395244C (zh) 2008-06-18
CN1314355A (zh) 2001-09-26

Similar Documents

Publication Publication Date Title
NO983625D0 (no) Kinolonkarboksylsyrederivater eller deres salter
NO20002169L (no) Nye pyridazinderivater og medikamenter inneholdende disse som effektive ingredienser
ATE264856T1 (de) Heterocyclisch substituierte benzolderivate und herbizide
ATE401312T1 (de) Pyrimidin-5-carboxamid-derivate
DE69628276D1 (de) Zubereitung von xanthinderivaten als feste dispersion
DE69426157D1 (de) 1,4-di(phenylalkyl)piperazinderivate
DE69813605D1 (de) Benzofuranderivate
BR9811273A (pt) Derivados de benzimidazol
DK0695755T3 (da) Pyrrolocarbazoler
FI970578A0 (fi) Uusia kinoloni- tai naftyridonikarboksyylihappojohdannaisia tai niiden suola
PT916651E (pt) DERIVADOS DE áCIDO FENILALQUILCARBOXILICO
ATE324362T1 (de) Neue vinylbenzolderivate
ATE209204T1 (de) Piperidinderivate.
DE69429185D1 (de) Imidazolidinon-derivate, deren säure-additionssalze und mittel gegen senile demenz
ATE396187T1 (de) Indolmethyl-n,n'-bisacylpiperazine als neurokininrezeptorantagonisten
ATE206125T1 (de) Furoindolizine
DE69837628D1 (de) Aminderivate, verfahren zu ihrer herstellung und ihre verwendung als antimykotische mittel
ATE242227T1 (de) Tetrahydrofuranderivate